These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23597)

  • 41. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
    Nair PN; Fernandes G; Onoe K; Day NK; Good RA
    Int J Cancer; 1980 May; 25(5):667-77. PubMed ID: 7372374
    [No Abstract]   [Full Text] [Related]  

  • 42. Mechanism of specifically induced non-specifically expressed cytotoxicity.
    Distasio JA; Lopez DM; Ghaffar A; Sigel MM; Silverman M
    J Reticuloendothel Soc; 1978 Aug; 24(2):161-67. PubMed ID: 81304
    [No Abstract]   [Full Text] [Related]  

  • 43. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 45. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
    Suit HD; Silobrcic V
    J Natl Cancer Inst; 1967 Dec; 39(6):1121-8. PubMed ID: 6079865
    [No Abstract]   [Full Text] [Related]  

  • 46. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
    Yamashita U; Hamaoka T
    J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
    Pitzurra M; Marconi P; Bistoni F
    Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL
    J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
    [No Abstract]   [Full Text] [Related]  

  • 50. Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells.
    Yunis EJ; Martinez C; Smith J; Stutman O; Good RA
    Cancer Res; 1969 Jan; 29(1):174-8. PubMed ID: 4303909
    [No Abstract]   [Full Text] [Related]  

  • 51. Allograft reaction against H-2-region antigens.
    Klein J
    Transplant Proc; 1977 Mar; 9(1):847-52. PubMed ID: 17202
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumor-specific transplantation immunity after cryosurgery.
    Myers RS; Hammond WG; Ketcham AS
    J Surg Oncol; 1969; 1(3):241-6. PubMed ID: 5406367
    [No Abstract]   [Full Text] [Related]  

  • 53. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
    [No Abstract]   [Full Text] [Related]  

  • 55. Alteration of cell-surface antigenicity of the mouse plasmacytoma. I. Immunologic characterization of surface antigens masked during successive transplantations.
    Ono S; Natsu-ume S; Migita S
    J Natl Cancer Inst; 1975 Sep; 55(3):569-77. PubMed ID: 51090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
    More R; Yron I; Weiss DW
    Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
    [No Abstract]   [Full Text] [Related]  

  • 57. The function of the immune response in tumour growth and its genetical regulation. A new hypothesis.
    Spärck JV
    Acta Pathol Microbiol Scand; 1969; 77(1):1-23. PubMed ID: 5368236
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.
    Hellström I; Hellström KE; Evans CA; Heppner GH; Pierce GE; Yang JP
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):362-8. PubMed ID: 5256215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymic dependency of tumor-induced immunodepression.
    Rowland GF; Edwards AJ; Sumner MR; Hurd CM
    J Natl Cancer Inst; 1973 May; 50(5):1329-36. PubMed ID: 4351396
    [No Abstract]   [Full Text] [Related]  

  • 60. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.